$POETF $POET CC Transcript 1: Suresh's Remarks 2:40

New Post Public Reply Private Reply Replies (1) Message Board
mc67
392
$POETF $POET CC Transcript 1: Suresh's Remarks

2:40 Suresh: “Thank you Brett. And good morning, good afternoon, good evening to all of you participating on today’s conference call. We appreciate you joining us on short notice and for your continued support. The primary purpose of today’s call is to discuss the two announcements made by the company over the past week and the positive implications they’re anticipated to have on POET’s business and strategy going forward. Beginning with the most recent news, on November 8th we announced the successful closing of the sale of the company’s subsidiary in Singapore. As many of you are aware, at a special meeting held on October 24th, POET shareholders voted in overwhelming support of the proposed transaction, with over 99% of submitted votes approving the sale of DenseLight. The now completed sale with net consideration of twenty-six million US dollars in cash, is to be paid out in three tranches. As indicated on Friday’s press release, the company received payment of the first tranche and the amount was US eight million at closing. And we simultaneously initiated the transfer of thirty percent of DenseLight’s shares to the buyer. The remaining seventy percent of Denselight’s shares will remain in escrow and will be transferred in conjunction with POET receiving each of the two remaining payments, of thirteen million and five million respectively, which are expected to be made on or before December 31st 2019 and May 31st, 2020. In addition to injecting capital to support our continued development activity, I want to emphasise two other benefits from the now completed sale. First, as of the closing, POET is now no longer responsible for the expenses of DenseLight, which reduces the company’s operating expenses and the previous overhead costs associated with maintaining a large fab. Then, also concurrent with the closing, the company repaid in full the bridge-loan with Espresso Capital and other parties, which allowed us to dissolve previously associated security interests in the assets of POET Technologies, as these were serving as collateral for the loans. As such the company’s assets today are not subject to any material leans. The first of these points is particularly important to POET’s ongoing development activities. Unburdened by the day-to-day operations of an under-loaded fab, POET is able to singularly be focused on the optical interposer design and development which, during the course of this year at certain times, took second priority as we were contractually obligated to maintain the fab asset in good working order prior to the sale.



5:40 As we commercialize the optical interposer into a true technology platform our ability to focus additional resources will be critical to extending the platform to address new applications. Before continuing I want to take a moment to acknowledge the tremendous effort put forth by the team to successfully close the sale of DenseLight. Without this dedication, perseverance, and tenacity we simply would not be in the same favourable position that we find ourselves in today. Our vision for the company continues to be for POET to be a Global leader chip-scale integrated photonic solutions. POET has and continues to be in the business of disruptive technology creation and unlocking its value and potential. Our means to achieving this vision is through the optical interposer, which is a true platform technology providing a physical means to combine electronics with all the key devices that are needed for photonics: lasers, modulators, waveguides, and importantly, for the first time, multiplexers and de-multiplexers, in the same wafer-scale form factor. Individual components can be mixed and matched into various configurations to meet the requirement of different applications. The optical interposer is of course enabled by our unique integration of low-loss optical waveguides and passive devices that are compatible with semiconductor fab processes and they enable this chip-scale packaging to be completed. This enablement of a seamless integration of varied devices, along with the ability to fabricate and test at wafer-scale, is what makes the optical interposer platform so disruptive with semiconductor scalability providing a highly disruptive cost advantage. No other company yet is at a comparable level of wafer-scale integration in photonics, especially when taken into account the integration of all the required passive components.



7:42 I’ve outlined during our presentation at the Annual General Meeting in late September, we believe the optimal path to commercializing our interposer technology is to intersect the emergence of the 400G transceiver market. This path is also being reinforced by the strong pull from our tier one strategic networking customer for 400G solutions. Therefor our focus today continues to be on the completion of the development of the platform building-blocks for our customer-specific 400G implementation by the end of the year. This would be followed by co-development of prototypical 400G optical engines. We set ourselves some aggressive goals at the start of the year with the change in focus to 400G. While we experienced some delays in development, those challenges have been overcome and our progress has been steady and we’ve maintained positive momentum. More specifically, we had initially divided our funded development program into eight distinct platform building block deliverables. We have successfully delivered seven of these deliverables and are focused on completing the final validation deliverable this year. This has allowed us to systematically retire major risk elements from the technology and this is crucial to any new technology implementation, particularly more so an industry leading one.



9:24 I’m further happy to announce that since the AGM, we have now successfully demonstrated all passive waveguide designs needed for the interposer engine. In addition to the de-multiplexer, we now have beta designs for the multiplexers, splitters, couplers, spot-size converters, and other such elements needed for a complete engine. Notably we have also demonstrated low-loss coupling from our custom designed lasers to the interposer waveguide for the first time, which is fundamental to the functionality of the interposer. In short, we’re making measured but tremendous progress. This is all the more commendable as we, in parallel, have set up a wholly owned new entity in Singapore, moved essential assets and support resources to a new facility, and of course worked through the process of closing the DenseLight transaction. As we also discussed at the AGM in December, no matter how smart our strategy or our technical approach, success or failure usually comes down to one thing: the team. And with that I want to transition to the other significant announcement we made this past week, the appointment of Vivek Rajgarhia as president and general manager of POET Technologies…


thanks to agoracom ITTR for posting this https://agoracom.com/ir/POETTechnologies/foru...47#message

POET Technologies Inc. (POET) Stock Research Links

POET Board Company Profile Buy Rating Time & Sales News Filings Financials
$MJ
Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 637

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 202

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 345

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 60

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 203

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 356

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 215

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 107

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 42

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Li Auto Inc. Reports Record Revenue and Milestone Deliveries

Updated Category News Views 89

Li Auto Inc. Announces Impressive Financial Results In the latest quarter, Li Auto Inc. reported a remarkable total revenue of RMB42.9 billion (approximately US$6.1 billion), showcasing a year-over-year growth of 23.6%. This impressive performance reflects the company's strong market presence and strategic execution. Quarterly Deliveries and Growth In terms of vehicle...

Continue Reading
LifeWallet's $2 Million Settlement and Strategic Progress Ahead

Updated Category News Views 162

LifeWallet's Recent Settlement Progress LifeWallet, formerly known as MSP Recovery, has recently made headlines by announcing a preliminary $2 million settlement as part of its portfolio of pharmaceutical litigation cases. This development is just one part of the company's broader strategy to engage various pharmaceutical and medical device manufacturers. The commitment...

Continue Reading
Revolutionary Approaches to Managing Resistant Hypertension

Updated Category News Views 261

Understanding Resistant Hypertension Resistant hypertension is a significant challenge for many patients, often referred to as the silent killer due to its insidious nature. Many individuals suffering from high blood pressure are unaware they have it, leading to severe health complications like cardiovascular disease over time. With the upcoming World Hypertension Day,...

Continue Reading
Understanding Wipro's Anticipated Earnings Performance

Updated Category News Views 51

Understanding Wipro's Anticipated Earnings Performance Wipro (WIT) is poised to release its latest quarterly earnings shortly. Investors are eager to gain insights from this upcoming report, which is shaping up to be a pivotal moment for the company. With analysts estimating an earnings per share (EPS) of $0.07, stakeholders are closely watching for news that could...

Continue Reading
Breakthrough Gene Therapy for Parkinson's Secures FDA Designation

Updated Category News Views 276

Significant FDA Recognition for AB-1005 AskBio Inc., known for its groundbreaking work in gene therapy, has made headlines with the announcement that its investigational gene therapy AB-1005 has received the esteemed Regenerative Medicine Advanced Therapy (RMAT) designation from the United States Food and Drug Administration (FDA). This acknowledgement comes on the heels...

Continue Reading